FDA.reportPublic FDA data

ixazomib 2.3 MG Oral Capsule

RxCUI
1723757
RxNorm name
ixazomib 2.3 MG Oral Capsule
Display name
ixazomib 2.3 MG Oral Capsule
Full name
ixazomib 2.3 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NINLAROIXAZOMIBTakeda Pharmaceuticals America, Inc.038f2461-834b-4488-9ebd-863c83eef5a72025-08-18Warnings, Adverse reactionsExact identifier
rxcui: 1723757

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
038f2461-834b-4488-9ebd-863c83eef5a7ixazomib 2.3 MG Oral Capsule [PSN] · ixazomib 2.3 MG Oral Capsule [SCD] · ixazomib 2.3 MG (as ixazomib citrate 3.3 MG) Oral Capsule [SY]316These highlights do not include all the information needed to use NINLARO safely and effectively. See full prescribing information for NINLARO. NINLARO ® (ixazomib) capsules, for oral use Initial U.S. Approval: 201520250818